The American journal of cardiology, 2003-09, Vol.92 (5), p.628-631
2003
Volltextzugriff (PDF)
Details
- Autor(en) / Beteiligte
- Titel
- Biological variation for N-Terminal Pro- and B-type natriuretic peptides and implications for therapeutic monitoring of patients with congestive heart failure
- Ist Teil von
- The American journal of cardiology, 2003-09, Vol.92 (5), p.628-631
- Ort / Verlag
- New York, NY: Elsevier Inc
- Erscheinungsjahr
- 2003
- Quelle
- MEDLINE
- Beschreibungen/Notizen
- Given the limitations of low enrollments, this study suggests that a change of 130% for B-type natiuretic peptide (BNP) and 90% for N-terminal (NT)-proBNP are necessary before results of serially collected data can be considered statistically different. This study also shows that there are important differences in the performance of BNP versus NT-proBNP in monitoring patients with congestive heart failure that need to be further explored.
- Sprache
- Englisch
- Identifikatoren
- ISSN: 0002-9149eISSN: 1879-1913DOI: 10.1016/S0002-9149(03)00741-0Titel-ID: cdi_proquest_miscellaneous_73616795
- Format
- –
- Schlagworte
- Adult, Analysis of Variance, Atrial Natriuretic Factor - blood, Biological and medical sciences, Biology, Biomarkers - blood, Cardiology. Vascular system, Case-Control Studies, Discriminant Analysis, Drug Monitoring - methods, Drug Monitoring - standards, Female, Heart, Heart failure, Heart Failure - blood, Heart Failure - classification, Heart Failure - diagnosis, Heart Failure - drug therapy, Heart failure, cardiogenic pulmonary edema, cardiac enlargement, Humans, Immunoassay - methods, Immunoassay - standards, Male, Medical sciences, Middle Aged, Natriuretic Peptide, Brain, Observer Variation, Patients, Peptides, Pilot Projects, Point-of-Care Systems - standards, Protein Precursors - blood, Radioimmunoassay - methods, Radioimmunoassay - standards, Reference Values, Sensitivity and Specificity, Severity of Illness Index, Therapy, Time Factors